BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2017 6:45:23 AM | Browse: 1559 | Download: 3578
 |
Received |
|
2017-02-21 10:29 |
 |
Peer-Review Started |
|
2017-02-22 17:35 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2017-04-06 12:15 |
 |
Revised |
|
2017-04-30 22:31 |
 |
Publication Fee Transferred |
|
2017-06-20 03:42 |
 |
Second Decision by Editor |
|
2017-06-16 12:17 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2017-06-19 08:41 |
 |
Articles in Press |
|
2017-06-19 08:41 |
 |
Edit the Manuscript by Language Editor |
|
2017-06-24 20:59 |
 |
Typeset the Manuscript |
|
2017-07-04 11:34 |
 |
Publish the Manuscript Online |
|
2017-07-12 06:45 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Jianpi Qingchang decoction regulates intestinal motility of dextran sulfate sodium-induced colitis through reducing autophagy of interstitial cells of Cajal
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yan-Cheng Dai, Lie Zheng, Ya-Li Zhang, Xuan Chen, De-Liang Chen, Li-Juan Wang and Zhi-Peng Tang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81403355 |
| National Natural Science Foundation of China |
81573892 |
| Project of 3-Year Action Plan for Shanghai Municipal Chinese Medicine Development |
ZY3-RCPY-2-2001 |
|
| Corresponding Author |
Zhi-Peng Tang, MD, PhD, Professor, Director, Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, 725 Wanping Road, Shanghai 200032, China. zhipengtang@sohu.com |
| Key Words |
intestinal motility; Interstitial cells of Cajal; autophagy; ulcerative colitis; Jianpi Qingchang decoction |
| Core Tip |
Interstitial cells of Cajal (ICC) lead to a variety of changes in the physiological properties of the neurons in the related circuitry, which then affects gastrointestinal motility. Therefore, ICC have been accepted as a therapeutic target for gastrointestinal motility disorders. It is demonstrated in the current study that Jianpi Qingchang decoction can regulate the intestinal motility of dextran sulfate sodium-induced colitis in mice through suppressing intestinal inflammatory cascade reaction, reducing autophagy of ICC, and regulating the network path of ICC/smooth muscle cells. |
| Publish Date |
2017-07-12 06:45 |
| Citation |
Dai YC, Zheng L, Zhang YL, Chen X, Chen DL, Wang LJ, Tang ZP. Jianpi Qingchang decoction regulates intestinal motility of dextran sulfate sodium-induced colitis through reducing autophagy of interstitial cells of Cajal. World J Gastroenterol 2017; 23(26): 4724-4734 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i26/4724.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i26.4724 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.